The book’s author, John Trowsdale, is a British scientist with an academic career of over 50 years, during which he has carried out ground-breaking research in the fields of genetics, immunology and molecular biology. Based largely on work carried out during his research career, Trowsdale presents here insights into how the immune system functions at the molecular level.
Read the news in brief from the EU from C&I Magazine Issue 12 2025.
The rising concentration of atmospheric carbon dioxide (CO2) is a major driver of climate change, with levels increasing from 280 parts per million (ppm) before the industrial revolution to 430ppm currently – with projections that it could reach 800ppm by 2100.
Expert scientists summarise some of their selected research papers from recent journal issues. Read the organic chemistry highlights from G. Richard Stephenson, University of East Anglia, UK in Issue 12 2025 of C&I magazine.
Pharma companies are increasingly harnessing AI to accelerate drug discovery. But will AI transform the hunt for new medicines, or are the benefits overhyped? Jasmin Fox-Skelly reports
Faster, safer and smarter tools accelerate scientific discovery. As of June 2025, a new initiative, SynHG (synthetic Human Genome), aims to develop scalable tools and technologies for synthesising human genomes. This five-year research project marks a bold step forward in genomics.
Bee pollen is regarded by many as something of a superfood, as it contains an array of carbohydrates, proteins, fats, fibre, vitamins and minerals - alongside the phenolic compounds seen as the source of pollen’s antioxidant capacities.
US researchers at NASA’s Oakridge site and Goddard Space Flight Center Maryland, and the University of Arizona, have discovered a range of prebiotic compounds formed abiotically on the carbonaceous asteroid Bennu in rock samples captured and returned by the OSIRIS-Rex space mission.
In regulated industries, the promise of AI is huge – faster decisions, deeper insights, greater efficiency. But so are the risks. Mission-critical applications demand more than cutting-edge algorithms or powerful models. They require responsible intelligence. AI that is auditable, explainable and aligned with regulatory standards from day one. That’s only possible when human expertise and AI innovation are brought together by design, not as an afterthought.
Advances in artificial intelligence (AI) tools have contributed to breakthroughs in protein design, but they also pose a growing biosecurity risk because they have the potential to produce ‘proteins of concern’. New analysis has found that some commercial screening systems weren’t flagging up potentially dangerous sequences. However, the researchers have now designed software patches to improve detection rates.